Genetic Mapping for Gynecological Disorders Test sale cost 3980 AED
GATA4 Gene Testicular anomalies with or without congenital heart disease Genetic Test sale cost 4400 AED GATA4 Gene Testicular anomalies with or without congenital heart disease Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Preimplantation Genetic Screening PGS Test sale cost 3280 AED Preimplantation Genetic Screening PGS Test 3,640 د.إ Original price was: 3,640 د.إ.3,280 د.إCurrent price is: 3,280 د.إ.
Sale!

Genetic Mapping for Gynecological Disorders Test

Original price was: 4,420 د.إ.Current price is: 3,980 د.إ.

-10%

Genetic Mapping for Gynecological Disorders Test is a cutting-edge diagnostic approach offered by DNA Labs UAE, aimed at identifying genetic predispositions to various gynecological conditions. This comprehensive test, priced at 3980 AED, leverages advanced genetic sequencing technologies to analyze a patient’s DNA for specific markers linked to disorders such as ovarian cancer, endometriosis, polycystic ovary syndrome (PCOS), and others. By pinpointing genetic vulnerabilities, this test enables individuals to take proactive measures in managing their health, potentially leading to early intervention and personalized treatment strategies. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test represents a significant step forward in personalized medicine, offering hope and empowerment to women at risk of gynecological disorders.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Genetic Mapping for Gynecological Disorders

Test Name: Genetic Mapping for Gynecological Disorders

Test Components: SNP Genotyping using Microarray

Test Price: 3980.0 AED

Sample Condition: Submit 3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genome Mapping Consent Form (Form 26) is mandatory.

Report Delivery: Sample Daily by 9 am; Report 8 weeks

Doctor: Gynecologist

Test Department: Molecular Diagnostics

Pre Test Information: Duly filled Genome Mapping Consent Form (Form 26) is mandatory.

Introduction

Genetic mapping for gynecological disorders refers to the process of identifying and locating genes associated with specific gynecological conditions. This involves studying the genetic variations and mutations that may contribute to the development of these disorders.

Objective

The aim of genetic mapping is to identify the specific genes or genetic markers that are associated with a particular gynecological disorder. This information can help in understanding the underlying causes of the disorder, predicting the risk of developing the condition, and developing targeted treatments or preventive measures.

Techniques Used

There are several techniques used in genetic mapping, including linkage analysis and association studies. Linkage analysis involves studying the inheritance patterns of genetic markers in families affected by the disorder. By comparing the genetic markers with the presence or absence of the disorder, researchers can identify regions of the genome that are likely to contain the disease-causing genes. Association studies, on the other hand, examine the frequency of specific genetic variations or mutations in individuals with the disorder compared to those without the disorder. This can help identify specific genes or genetic variations that are more common in individuals with the disorder, suggesting a potential association.

Applications

Genetic mapping for gynecological disorders has been used to study conditions such as endometriosis, polycystic ovary syndrome (PCOS), uterine fibroids, ovarian cancer, and cervical cancer, among others. By identifying the genes and genetic variations associated with these disorders, researchers hope to improve diagnosis, develop targeted treatments, and potentially prevent these conditions in the future.

It is important to note that genetic mapping is a complex and ongoing process, and not all gynecological disorders have identified genetic markers or causative genes. However, advancements in genetic research and technology continue to expand our understanding of the genetic basis of these disorders and offer new possibilities for personalized medicine in gynecology.

Test Name GENETIC MAPPING FOR GYNECOLOGICAL DISORDERS Test
Components
Price 3980.0 AED
Sample Condition Submit 3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube.Ship refrigerated. DO NOT FREEZE. Duly filled Genome Mapping Consent Form (Form 26) is mandatory.
Report Delivery Sample Daily by 9 am; Report 8 weeks
Method SNP Genotyping using Microarray
Test type Disorder of Reproductive system
Doctor Gynecologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genome Mapping Consent Form (Form 26) is mandatory.
Test Details

Genetic mapping for gynecological disorders refers to the process of identifying and locating genes associated with specific gynecological conditions. This involves studying the genetic variations and mutations that may contribute to the development of these disorders.

The aim of genetic mapping is to identify the specific genes or genetic markers that are associated with a particular gynecological disorder. This information can help in understanding the underlying causes of the disorder, predicting the risk of developing the condition, and developing targeted treatments or preventive measures.

There are several techniques used in genetic mapping, including linkage analysis and association studies. Linkage analysis involves studying the inheritance patterns of genetic markers in families affected by the disorder. By comparing the genetic markers with the presence or absence of the disorder, researchers can identify regions of the genome that are likely to contain the disease-causing genes.

Association studies, on the other hand, examine the frequency of specific genetic variations or mutations in individuals with the disorder compared to those without the disorder. This can help identify specific genes or genetic variations that are more common in individuals with the disorder, suggesting a potential association.

Genetic mapping for gynecological disorders has been used to study conditions such as endometriosis, polycystic ovary syndrome (PCOS), uterine fibroids, ovarian cancer, and cervical cancer, among others. By identifying the genes and genetic variations associated with these disorders, researchers hope to improve diagnosis, develop targeted treatments, and potentially prevent these conditions in the future.

It is important to note that genetic mapping is a complex and ongoing process, and not all gynecological disorders have identified genetic markers or causative genes. However, advancements in genetic research and technology continue to expand our understanding of the genetic basis of these disorders and offer new possibilities for personalized medicine in gynecology.

SKU: TEST-4668 Category:

Related products